![](https://www.businessmarketinsights.com/assets/img/reports-icon.png)
Previsioni di mercato di enzimi, kit e reagenti per biologia molecolare del Nord America fino al 2028 – Impatto del COVID-19 e analisi regionale per prodotto (enzimi, kit e reagenti), applicazione (epigenetica, sequenziamento, biologia sintetica, reazione a catena della polimerasi e altro) e Utente finale (aziende biotecnologiche e farmaceutiche, ospedali e centri diagnostici e istituti accademici e di ricerca)
Introduzione al mercato
Il Nord America è il più grande mercato per enzimi, kit e prodotti per biologia molecolare. reagenti, con gli Stati Uniti che detengono la quota di mercato maggiore, seguiti dal Canada. La crescita in Nord America è caratterizzata da una crescente incidenza di cancro, da attori chiave del mercato affermati e da un’ampia attività di ricerca e sviluppo condotta da vari istituti accademici e di ricerca. Inoltre, la crescente incidenza di COVID-19 sostiene la crescita del mercato durante il periodo di previsione. I crescenti investimenti e i crescenti fondi dedicati alle aziende manifatturiere, nonché agli istituti accademici e di ricerca per lo sviluppo di farmaci contro il cancro, la crescita della popolazione geriatrica, le malattie infettive e altre terapie sono uno dei principali fattori trainanti.
La pandemia COVID-19 aveva mostrato uno scenario favorevole per gli operatori che operano nei settori degli enzimi, dei kit e delle tecnologie di biologia molecolare. mercato dei reagenti. Gli Stati Uniti sono stati un paese fortemente colpito nel Nord America. L’effetto del COVID-19 è negativo nelle persone geriatriche. L’infezione da COVID-19 tra le persone anziane ha provocato gravi complicazioni e ha causato molti decessi nel Paese. Durante la pandemia, le aziende del settore delle scienze della vita erano impegnate nello sviluppo di nuovi farmaci per il trattamento di malattie potenzialmente letali. Pertanto, enzimi, kit e amp; i prodotti reagenti sono necessari nella progettazione e nella progettazione dei farmaci. sviluppo e diagnosi di COVID-19.
Inoltre, il numero crescente di casi di COVID-19 ha avuto un impatto positivo sugli enzimi, sui kit e sui prodotti di biologia molecolare. mercato dei reagenti. Nel marzo 2021, la Clinical Enterprise, Inc. di Eurofins ha ottenuto un\'autorizzazione all\'uso di emergenza (EUA) dalla Food and Drug Administration (FDA) statunitense per una versione diretta al consumatore (DTC) del suo kit di raccolta domestica EmpowerDX COVID-19. Il kit PCR nasale per COVID-19 a domicilio Eurofins è uno dei primi kit per test domiciliari SARS-CoV-2 da banco approvati dall\'Unione Europea. Pertanto, il numero crescente di lanci di prodotti supporta la crescita del mercato. Allo stesso modo, nel luglio 2020, Eurofins US Clinical Diagnostics ha annunciato la disponibilità del suo test PCR in pool per rilevare la SARS-CoV-2, che ridurrebbe sostanzialmente il costo per test PCR per i clienti.
< u>Panoramica e dinamiche del mercato
Si prevede che il mercato degli enzimi, dei kit e dei reagenti per biologia molecolare in Nord America crescerà da 5.532,13 milioni di dollari nel 2021 a 17.999,75 milioni di dollari entro il 2028; si stima che crescerà a un CAGR del 18,4% dal 2021 al 2028. Secondo i suggerimenti dell\'OMS, il 30-50% dei decessi causati dal cancro può essere prevenuto con un trattamento adeguato nelle fasi iniziali. In questo scenario, la medicina personalizzata offre l’approccio più promettente per affrontare malattie che non sono note per rispondere efficacemente ai trattamenti o alle cure esistenti. Secondo uno studio pubblicato sul PMC, nel 2005 i farmaci personalizzati rappresentavano solo il 5% delle nuove entità molecolari approvate dalla FDA, mentre nel 2016 rappresentavano oltre il 25%. Inoltre, il 42% di tutti i composti e 73 Il % dei composti oncologici in cantiere hanno il potenziale per diventare farmaci personalizzati. Inoltre, negli ultimi cinque anni le aziende biofarmaceutiche hanno quasi raddoppiato i propri investimenti in ricerca e sviluppo in farmaci personalizzati e si prevede che aumenteranno del 33% nei prossimi cinque anni. I ricercatori biofarmaceutici prevedono inoltre un aumento del 69% del numero di farmaci personalizzati in fase di sviluppo nei prossimi cinque anni.
Segmenti chiave del mercato
Il mercato degli enzimi, dei kit e dei reagenti per biologia molecolare in Nord America è segmentato in prodotti , applicazione, utente finale e paese. In base al prodotto, il mercato degli enzimi, dei kit e dei reagenti per biologia molecolare è suddiviso in enzimi e kit e amp; reagenti. Il mercato, per enzimi, è ulteriormente segmentato in polimerasi, ligasi, trascrittasi inversa, fosfatasi, proteasi e proteinasi, endonucleasi di restrizione e altro. I kit e gli accessori Il segmento dei reagenti ha detenuto una quota di mercato maggiore nel 2020. Il mercato degli enzimi, dei kit e dei reagenti per biologia molecolare, in base all\'applicazione, è segmentato in epigenetica, sequenziamento, biologia sintetica, reazione a catena della polimerasi e altro. Nel 2020, il segmento del sequenziamento deteneva la quota di mercato maggiore. In termini di utente finale, il mercato degli enzimi, dei kit e dei reagenti per biologia molecolare è segmentato in aziende biotecnologiche e farmaceutiche, ospedali e centri diagnostici e istituti accademici e di ricerca. Il segmento delle aziende biotecnologiche e farmaceutiche ha detenuto la quota maggiore del mercato nel 2020. In base al paese, il mercato degli enzimi, dei kit e dei reagenti per biologia molecolare del Nord America è segmentato in Stati Uniti, Canada e Messico. Gli Stati Uniti hanno detenuto la quota di mercato maggiore nel 2020.
Principali fonti e società elencate
Alcune delle principali fonti primarie e secondarie citate Per preparare questo rapporto sul mercato degli enzimi, kit e reagenti per biologia molecolare in Nord America sono siti Web aziendali, relazioni annuali, rapporti finanziari, documenti governativi nazionali e database statistici, tra gli altri. Le principali aziende elencate nel rapporto sono Agilent Technologies, Inc.; F. HOFFMANN-LA ROCHE LTD; Illumina, Inc.; Merck KGAA; MERIDIAN BIOSCIENCE, INC; Promega Corporation; Qiagen; Rockland Immunochemicals Inc; e THERMO FISHER SCIENTIFIC INC.
Motivi per acquistare il rapporto
- Comprendere il panorama del mercato degli enzimi, dei kit e dei reagenti per biologia molecolare nel Nord America e identificare i segmenti di mercato che hanno maggiori probabilità di garantire un forte rendimento.
- Stai al passo con la corsa comprendendo il panorama competitivo in continua evoluzione del mercato degli enzimi, dei kit e dei reagenti per biologia molecolare del Nord America.
- Pianifica in modo efficiente operazioni di fusione e acquisizione e accordi di partnership nel Nord America Mercato americano di enzimi, kit e reagenti per biologia molecolare identificando i segmenti di mercato con le vendite probabili più promettenti.
- Aiuta a prendere decisioni aziendali consapevoli dall\'analisi perspicace e completa delle prestazioni di mercato di vari segmenti della biologia molecolare del Nord America mercato degli enzimi, dei kit e dei reagenti.
- Ottieni previsioni sulle entrate del mercato per vari segmenti dal 2021 al 2028 nella regione del Nord America.
Nord America Mercato degli enzimi, kit e reagenti per biologia molecolare Segmentazione
Nord America Mercato di biologia molecolare di enzimi, kit e reagenti - Per prodotto
- Enzimi
- Polimerasi
- Ligasi
- Trascrittasi inverse
- Fosfatasi
- Proteasi e proteinasi
- Endonucleasi di restrizione
- Altro
- Kit e reagenti
Mercato degli enzimi, dei kit e dei reagenti per la biologia molecolare del Nord America - A cura di Applicazione
- Epigenetica
- Sequenziamento
- Biologia sintetica
- Reazione a catena della polimerasi
- Altro
Mercato degli enzimi, dei kit e dei reagenti per biologia molecolare in Nord America - per utente finale
- Aziende biotecnologiche e farmaceutiche
- Ospedali e centri diagnostici
- Istituti accademici e di ricerca
Mercato degli enzimi, dei kit e dei reagenti per biologia molecolare in Nord America - Per paese
- Stati Uniti
- Canada
- Messico
Mercato di enzimi, kit e reagenti per biologia molecolare in Nord America - Profili aziendali
- Agilent Technologies , Inc.
- F. HOFFMANN-LA ROCHE LTD
- Illumina, Inc.
- Merck KGAA
- MERIDIAN BIOSCIENCE, INC
- Promega Corporation
- Qiagen
- Rockland Immunochemicals Inc
- THERMO FISHER SCIENTIFIC INC
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Molecular Biology Enzymes, Kits & Reagents Market – By Product
1.3.2 North America Molecular Biology Enzymes, Kits & Reagents Market – By Application
1.3.3 North America Molecular Biology Enzymes, Kits & Reagents Market – By End-User
1.3.4 North America Molecular Biology Enzymes, Kits & Reagents Market – By Country
2. North America Molecular Biology Enzymes, Kits & Reagents Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Molecular Biology Enzymes, Kits & Reagents Market – Market Landscape
4.1 North America PEST Analysis
4.1.1 Expert Opinion
5. North America Molecular Biology Enzymes, Kits & Reagents Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Genomics Getting Highly Funded
5.1.2 Sequencing Procedures becoming Cheaper
5.1.3 Rising Prevalence of Chronic Diseases
5.2 Market Restraints
5.2.1 Scarcity of Skilled Professionals
5.3 Market Opportunities
5.3.1 Molecular Diagnostics Getting Highly Adopted
5.4 Future Trends
5.4.1 Personalized Medicines at High Demand
5.5 Impact analysis
6. Molecular Biology Enzymes, Kits & Reagents Market – North America Analysis
6.1 North America Molecular Biology Enzymes, Kits & Reagents Market Revenue Forecast and Analysis
7. North America Molecular Biology Enzymes, Kits & Reagents Market Analysis – By Product
7.1 Overview
7.2 North America Molecular Biology Enzymes, Kits & Reagents Market Revenue Share, by Product (2020 and 2028)
7.3 Enzymes
7.3.1 Overview
7.3.2 Enzymes: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 Polymerases
7.3.3.1 Overview
7.3.3.2 Polymerases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
7.3.4 Ligase
7.3.4.1 Overview
7.3.4.2 Ligase: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
7.3.5 Reverse Transcriptases
7.3.5.1 Overview
7.3.5.2 Reverse Transcriptases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
7.3.6 Phosphatases
7.3.6.1 Overview
7.3.6.2 Phosphatases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
7.3.7 Proteases and Proteinases
7.3.7.1 Overview
7.3.7.2 Proteases and Proteinases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
7.3.8 Restriction Endonuclease
7.3.8.1 Overview
7.3.8.2 Restriction Endonuclease: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
7.3.9 Other
7.3.9.1 Overview
7.3.9.2 Other: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Kits and Reagents
7.4.1 Overview
7.4.2 Kits and Reagents: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
8. North America Molecular Biology Enzymes, Kits & Reagents Market Analysis – By Application
8.1 Overview
8.2 North America Molecular Biology Enzymes, Kits & Reagents Market Revenue Share, by Application (2020 and 2028)
8.3 Polymerase Chain Reaction
8.3.1 Overview
8.3.2 Polymerase Chain Reaction: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Sequencing
8.4.1 Overview
8.4.2 Sequencing: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Synthetic Biology
8.5.1 Overview
8.5.2 Synthetic Biology: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Epigenetics
8.6.1 Overview
8.6.2 Epigenetics: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
9. North America Molecular Biology Enzymes, Kits & Reagents Market – By End User
9.1 Overview
9.2 North America Molecular Biology Enzymes, Kits & Reagents Market, by End User, 2020 and 2028 (%)
9.3 Biotechnological and Pharmaceutical Companies
9.3.1 Overview
9.3.2 Biotechnological and Pharmaceutical Companies: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Hospitals and Diagnostic Centers
9.4.1 Overview
9.4.2 Hospitals and Diagnostic Centers: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Academic and Research Institutes
9.5.1 Overview
9.5.2 Academic and Research Institutes: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
10. North America Molecular Biology Enzymes, Kits & Reagents Market – Country Analysis
10.1 North America
10.1.1 Overview
10.1.2 North America: Molecular Biology Enzymes, Kits & Reagents Market, by Country, 2020 & 2028 (%)
10.1.2.1 US
10.1.2.1.1 US: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.2 US: Molecular Biology Enzymes, Kits & Reagents Market, by Product, 2019–2028 (USD Million)
10.1.2.1.3 US: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes, 2019–2028 (USD Million)
10.1.2.1.4 US: Molecular Biology Enzymes, Kits & Reagents Market, by Application, 2019–2028 (USD Million)
10.1.2.1.5 US: Molecular Biology Enzymes, Kits & Reagents Market, by End User, 2019–2028 (USD Million)
10.1.2.2 Canada
10.1.2.2.1 Canada: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.2 Canada: Molecular Biology Enzymes, Kits & Reagents Market, by Product, 2019–2028 (USD Million)
10.1.2.2.3 Canada: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes, 2019–2028 (USD Million)
10.1.2.2.4 Canada: Molecular Biology Enzymes, Kits & Reagents Market, by Application, 2019–2028 (USD Million)
10.1.2.2.5 Canada: Molecular Biology Enzymes, Kits & Reagents Market, by End User, 2019–2028 (USD Million)
10.1.2.3 Mexico
10.1.2.3.1 Mexico: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.2 Mexico: Molecular Biology Enzymes, Kits & Reagents Market, by Product, 2019–2028 (USD Million)
10.1.2.3.3 Mexico: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes, 2019–2028 (USD Million)
10.1.2.3.4 Mexico: Molecular Biology Enzymes, Kits & Reagents Market, by Application, 2019–2028 (USD Million)
10.1.2.3.5 Mexico: Molecular Biology Enzymes, Kits & Reagents Market, by End User, 2019–2028 (USD Million)
11. Impact of COVID-19 Pandemic on North America Molecular Biology Enzymes, Kits & Reagents Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
12. Molecular Biology Enzymes, Kits & Reagents Market Industry Landscape
12.1 Overview
12.2 Growth Strategies In The Molecular Biology Enzymes, Kits & Reagents Devices Market, 2018-2021
12.3 Organic Growth Strategies
12.3.1 Overview
12.3.2 Recent Organic Developments in the Molecular Biology Enzymes, Kits & Reagents Market
12.4 Inorganic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 HOFFMANN-LA ROCHE LTD.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 MERCK KGaA
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Illumina, Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 QIAGEN
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Agilent Technologies, Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Rockland Immunochemicals, Inc
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 THERMO FISHER SCIENTIFIC INC.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 MERIDIAN BIOSCIENCE, INC.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Promega Corporation
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. US: Molecular Biology Enzymes, Kits & Reagents Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 2. US: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes– Revenue and Forecast to 2028 (USD Million)
Table 3. US: Molecular Biology Enzymes, Kits & Reagents Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 4. US: Molecular Biology Enzymes, Kits & Reagents Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 5. Canada: Molecular Biology Enzymes, Kits & Reagents Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 6. Canada: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes– Revenue and Forecast to 2028 (USD Million)
Table 7. Canada: Molecular Biology Enzymes, Kits & Reagents Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 8. Canada: Molecular Biology Enzymes, Kits & Reagents Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 9. Mexico: Molecular Biology Enzymes, Kits & Reagents Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 10. Mexico: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes– Revenue and Forecast to 2028 (USD Million)
Table 11. Mexico: Molecular Biology Enzymes, Kits & Reagents Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 12. Mexico: Molecular Biology Enzymes, Kits & Reagents Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 13. Recent Inorganic Developments In The Molecular Biology Enzymes, Kits & Reagents Market
Table 14. Glossary of Terms, Molecular Biology Enzymes, Kits & Reagents Market
LIST OF FIGURES
Figure 1. North America Molecular Biology Enzymes, Kits & Reagents Market Segmentation
Figure 2. North America Molecular Biology Enzymes, Kits & Reagents Market Segmentation, By Country
Figure 3. North America Molecular Biology Enzymes, Kits & Reagents Market Overview
Figure 4. Kits and Reagents Segment Held Largest Share of North America Molecular Biology Enzymes, Kits & Reagents Market
Figure 5. US to Show Remarkable Growth During Forecast Period
Figure 6. North America PEST Analysis
Figure 7. North America Molecular Biology Enzymes, Kits, and Reagents Market Impact Analysis of Driver and Restraints
Figure 8. North America Molecular Biology Enzymes, Kits & Reagents Market – Revenue Forecast and Analysis – 2020- 2028
Figure 9. North America Molecular Biology Enzymes, Kits & Reagents Market Revenue Share, by Product (2020 and 2028)
Figure 10. North America Enzymes: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. North America Polymerases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. North America Ligase: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. North America Reverse Transcriptases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. North America Phosphatases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. North America Proteases and Proteinases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. North America Restriction Endonuclease: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. North America Others: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. North America Kits and Reagents: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. North America Molecular Biology Enzymes, Kits & Reagents Market Revenue Share, by Application (2020 and 2028)
Figure 20. North America Polymerase Chain Reaction: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. North America Sequencing: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. North America Synthetic Biology: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. North America Epigenetics: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. North America Others: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. North America Molecular Biology Enzymes, Kits & Reagents Market, by End User, 2020 and 2028 (%)
Figure 26. North America Biotechnological and Pharmaceutical Companies: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. North America Hospitals and Diagnostic Centers: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. North America Academic and Research Institute: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. North America: Molecular Biology Enzymes, Kits & Reagents Market, by Key Country – Revenue (2020) (USD Million)
Figure 30. North America: Molecular Biology Enzymes, Kits & Reagents Market, by Country, 2020 & 2028 (%)
Figure 31. US: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)
Figure 32. Canada: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)
Figure 33. Mexico: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)
Figure 34. Impact of COVID-19 Pandemic in North American Country Markets
Figure 35. Growth Strategies In The Molecular Biology Enzymes, Kits & Reagents Devices Market, 2018-2021
- Agilent Technologies, Inc.
- F. HOFFMANN-LA ROCHE LTD
- Illumina, Inc.
- Merck KGAA
- MERIDIAN BIOSCIENCE, INC
- Promega Corporation
- Qiagen
- Rockland Immunochemicals Inc
- THERMO FISHER SCIENTIFIC INC
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America molecular biology enzymes, kits, and reagents market
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the North America molecular biology enzymes, kits, and reagents market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the molecular biology enzymes, kits, and reagents market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution